Prestige Consumer Healthcare Return on Investment 2010-2024 | PBH
Current and historical return on investment (ROI) values for Prestige Consumer Healthcare (PBH) over the last 10 years.
| Prestige Consumer Healthcare ROI - Return on Investment Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | LT Investments & Debt | Return on Investment |
| 2024-12-31 | $0.33B | $2.78B | 11.87% |
| 2024-09-30 | $0.33B | $2.78B | 11.67% |
| 2024-06-30 | $0.33B | $2.77B | 11.80% |
| 2024-03-31 | $0.34B | $2.78B | 12.24% |
| 2023-12-31 | $-0.02B | $2.80B | -0.75% |
| 2023-09-30 | $-0.02B | $2.80B | -0.73% |
| 2023-06-30 | $-0.03B | $2.80B | -0.85% |
| 2023-03-31 | $-0.02B | $2.80B | -0.76% |
| 2022-12-31 | $0.34B | $3.11B | 10.90% |
| 2022-09-30 | $0.33B | $3.06B | 10.82% |
| 2022-06-30 | $0.33B | $3.06B | 10.66% |
| 2022-03-31 | $0.33B | $3.06B | 10.87% |
| 2021-12-31 | $0.32B | $3.05B | 10.87% |
| 2021-09-30 | $0.31B | $3.06B | 10.69% |
| 2021-06-30 | $0.31B | $2.97B | 10.69% |
| 2021-03-31 | $0.30B | $2.85B | 10.41% |
| 2020-12-31 | $0.30B | $2.88B | 10.46% |
| 2020-09-30 | $0.30B | $2.84B | 10.58% |
| 2020-06-30 | $0.30B | $2.85B | 10.41% |
| 2020-03-31 | $0.29B | $2.91B | 10.07% |
| 2019-12-31 | $0.06B | $2.86B | 2.19% |
| 2019-09-30 | $0.07B | $2.87B | 2.22% |
| 2019-06-30 | $0.07B | $2.88B | 2.24% |
| 2019-03-31 | $0.07B | $2.89B | 2.23% |
| 2018-12-31 | $0.20B | $3.08B | 6.34% |
| 2018-09-30 | $0.20B | $3.09B | 6.43% |
| 2018-06-30 | $0.21B | $3.16B | 6.64% |
| 2018-03-31 | $0.22B | $3.17B | 6.95% |
| 2017-12-31 | $0.29B | $3.27B | 9.51% |
| 2017-09-30 | $0.28B | $2.99B | 9.87% |
| 2017-06-30 | $0.27B | $3.00B | 10.37% |
| 2017-03-31 | $0.21B | $3.02B | 8.37% |
| 2016-12-31 | $0.22B | $2.22B | 9.48% |
| 2016-09-30 | $0.21B | $2.25B | 9.27% |
| 2016-06-30 | $0.21B | $2.32B | 9.32% |
| 2016-03-31 | $0.26B | $2.37B | 11.78% |
| 2015-12-31 | $0.26B | $2.17B | 11.84% |
| 2015-09-30 | $0.25B | $2.16B | 11.46% |
| 2015-06-30 | $0.23B | $2.17B | 10.27% |
| 2015-03-31 | $0.21B | $2.19B | 10.06% |
| 2014-12-31 | $0.19B | $2.25B | 10.13% |
| 2014-09-30 | $0.18B | $2.28B | 10.21% |
| 2014-06-30 | $0.18B | $1.56B | 11.94% |
| 2014-03-31 | $0.19B | $1.50B | 12.54% |
| 2013-12-31 | $0.19B | $1.53B | 12.98% |
| 2013-09-30 | $0.20B | $1.52B | 13.60% |
| 2013-06-30 | $0.20B | $1.45B | 13.40% |
| 2013-03-31 | $0.19B | $1.45B | 12.93% |
| 2012-12-31 | $0.17B | $1.46B | 10.97% |
| 2012-09-30 | $0.14B | $1.52B | 10.54% |
| 2012-06-30 | $0.12B | $1.52B | 10.19% |
| 2012-03-31 | $0.10B | $1.53B | 10.20% |
| 2011-12-31 | $0.10B | $0.83B | 11.78% |
| 2011-09-30 | $0.09B | $0.84B | 10.39% |
| 2011-06-30 | $0.08B | $0.84B | 10.40% |
| 2011-03-31 | $0.08B | $0.85B | 10.33% |
| 2010-12-31 | $0.08B | $0.86B | 10.88% |
| 2010-09-30 | $0.09B | $0.64B | 13.38% |
| 2010-06-30 | $0.08B | $0.63B | 12.72% |
| 2010-03-31 | $0.08B | $0.62B | 12.28% |
| 2009-12-31 | $-0.17B | $0.64B | -26.12% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.171B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.085B | 27.79 |
| Boston Scientific (BSX) | United States | $155.238B | 38.86 |
| Stryker (SYK) | United States | $144.362B | 30.18 |
| EssilorLuxottica (ESLOY) | France | $132.860B | 0.00 |
| Medtronic (MDT) | Ireland | $108.824B | 15.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.259B | 27.44 |
| ResMed (RMD) | United States | $35.183B | 26.43 |
| GE HealthCare Technologies (GEHC) | United States | $32.295B | 15.33 |
| Agilent Technologies (A) | United States | $30.971B | 20.46 |
| Terumo (TRUMY) | Japan | $29.019B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.053B | 17.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.255B | 12.80 |
| Insulet (PODD) | United States | $18.084B | 77.18 |
| Baxter (BAX) | United States | $15.752B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.535B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.447B | 18.31 |
| Bio-Rad Laboratories (BIO) | United States | $6.620B | 22.38 |
| Perrigo (PRGO) | Ireland | $3.497B | 10.01 |
| ICU Medical (ICUI) | United States | $3.486B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.208B | 15.10 |
| Envista Holdings (NVST) | United States | $2.880B | 23.93 |
| GN Store Nord (GNNDY) | Denmark | $2.068B | 17.13 |
| QuidelOrtho (QDEL) | United States | $1.964B | 16.45 |
| LeMaitre Vascular (LMAT) | United States | $1.778B | 39.75 |
| AtriCure (ATRC) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 21.63 |
| Neogen (NEOG) | United States | $1.248B | 15.97 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.200B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.184B | 11.40 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.789B | 12.10 |
| Evolus (EOLS) | United States | $0.779B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.637B | 0.00 |
| CeriBell (CBLL) | United States | $0.588B | 0.00 |
| Owens & Minor (OMI) | United States | $0.580B | 4.94 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.458B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.418B | 0.00 |
| Surmodics (SRDX) | United States | $0.395B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 15.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.296B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.291B | 26.32 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 48.40 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.60 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.233B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.231B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Biote (BTMD) | United States | $0.190B | 4.35 |
| Utah Medical Products (UTMD) | United States | $0.173B | 13.93 |
| Brainsway (BWAY) | Israel | $0.170B | 53.06 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Organigram Global (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.22 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.108B | 0.00 |
| Agape ATP (ATPC) | $0.099B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 61.50 |
| United-Guardian (UG) | United States | $0.037B | 11.28 |
| Safety Shot (SHOT) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |